Lymphocyte-to-Monocyte Ratio Predicts Survival for Intraductal Papillary Mucinous Neoplasm with Associated Invasive Carcinoma of the Pancreas: Results from a High-Volume Center
Open Access
- 18 July 2024
- journal article
- research article
- Published by S. Karger AG in Digestive Surgery
- Vol. 41 (3) , 111-121
Abstract
Introduction: Intraductal papillary mucinous neoplasm (IPMN) is an important precursor lesion of pancreatic cancer. Systemic inflammatory parameters are widely used in the prognosis prediction of cancer; however, their prognostic implications in IPMN with associated invasive carcinoma (IPMN-INV) are unclear. This study aims to explore the prognostic value of systemic inflammatory parameters in patients with IPMN-INV. Methods: From 2015 to 2021, patients with pathologically confirmed IPMN who underwent surgical resection at Peking Union Medical College Hospital were enrolled. The clinical, radiological, and pathological data of the enrolled patients were collected and analyzed. Preoperative systemic inflammatory parameters were calculated as previously reported. Results: Eighty-six patients with IPMN-INV met the inclusion criteria. The lymphocyte-to-monocyte ratio (LMR) was the only systemic inflammatory parameter independently associated with the cancer-specific survival (CSS). An LMR higher than 3.5 was significantly associated with a favorable CSS in univariate (hazard ratio [HR] 0.305, p = 0.003) and multivariate analyses (HR 0.221, p = 0.001). Other independently prognostic factors included the presence of clinical symptoms, cyst size, N stage, and tumor differentiation. Additionally, a model including LMR was established for the prognosis prediction of IPMN-INV and had a C-index of 0.809. Conclusions: Preoperative LMR could serve as a feasible prognostic biomarker for IPMN-INV. A decreased LMR (cutoff value of 3.5) was an independent predictor of poor survival for IPMN-INV.Keywords
This publication has 32 references indexed in Scilit:
- IPMN-associated pancreatic cancer: Survival, prognostic staging and impact of adjuvant chemotherapyEuropean Journal of Surgical Oncology, 2022
- The diagnostic and prognostic values of inflammatory markers in intraductal papillary mucinous neoplasmHPB, 2021
- Analyzing and predicting the LNM rate and prognosis of patients with intraductal papillary mucinous neoplasm of the pancreasCancer Medicine, 2021
- External validation of the prognostic relevance of the advanced lung cancer inflammation index (ALI) in pancreatic cancer patientsCancer Medicine, 2020
- Peripheral blood monocyte counts are elevated in the pre-diagnostic phase of pancreatic cancer: A population based studyPancreatology, 2019
- Intraductal papillary mucinous carcinoma versus pancreatic ductal adenocarcinoma: A systematic review and meta-analysisInternational Journal of Surgery, 2019
- Inflammation and Cancer: Triggers, Mechanisms, and ConsequencesImmunity, 2019
- Systematic review and meta-analysis: Prevalence of incidentally detected pancreatic cystic lesions in asymptomatic individualsPancreatology, 2019
- Prognostic role of the neutrophil-to-lymphocyte ratio in pancreatic cancer: A meta-analysis containing 8252 patientsClinica Chimica Acta, 2018
- Surgical treatment and prognosis of 96 cases of intraductal papillary mucinous neoplasms of the pancreas: A retrospective cohort studyInternational Journal of Surgery, 2015